Clinical trial
A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose
NCT00114855 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose
- Lead sponsor
- Oslo University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- June 30, 2006
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glucose metabolism disorders, hyperlipidemia